Reducing Hemodialysis Catheter Use in Prevalent Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if a protocolized approach to converting hemodialysis central venous catheters (CVC) to arteriovenous fistulae will improve rates of functioning AVF and decrease CVC use.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Open Versus Percutaneous Insertion of CAPD Catheters

NCT01023191

Renal Failure

WITHDRAWN NA

Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit

NCT02374372

Chronic Renal Failure Hemodialysis

COMPLETED NA

PD Catheter Data Collection

NCT07156123

Renal Insufficiency / Therapy

NOT_YET_RECRUITING

Hemodialysis in the Elderly (70yrs & Older)

NCT03065972

Kidney Disease Kidney Failure Chronic Kidney Disease

UNKNOWN NA

A Comparative Study of Two Kinds of Hemodialysis Filters

NCT05899283

Uremia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to receive dialysis, patients require repeated access to their bloodstream. This access can be either via a central venous catheter (CVC) or a surgically created arteriovenous fistula (AVF) or graft (AVG). This is a pilot randomized control trial of prevalent hemodialysis patients with a central venous catheter (CVC), to determine if a systematic approach using an algorithm protocol to convert the CVC to an AVF (arteriovenous fistula) will improve rates of functioning AVF and decrease CVC use. The algorithm (intervention group) will be compared to current practice (control group), a non-standardized approach at the discretion of the caring nephrologist and/or surgeon.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Protocolized approach

Protocolized approach to convert catheter to arteriovenous fistula

Group Type EXPERIMENTAL

Protocolized approach to convert dialysis catheter to fistula

Intervention Type OTHER

This group will be assigned an algorithm protocol in efforts to convert the central venous catheter to an arteriovenous fistula. A case manager will be assigned to follow these patients and implement the protocol

Current Care Model

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protocolized approach to convert dialysis catheter to fistula

This group will be assigned an algorithm protocol in efforts to convert the central venous catheter to an arteriovenous fistula. A case manager will be assigned to follow these patients and implement the protocol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 18 years of age
* Dialyzing with a CVC
* Receiving hemodialysis three times weekly for \> 3 months

Exclusion Criteria

* Awaiting peritoneal dialysis catheter insertion
* Scheduled living donor transplant
* Transient patients from out of province
* Expected transfer to satellite dialysis unit within 6 months
* Surgical plan for AVF (i.e. scheduled date)
* Documented lack of suitable vasculature for AVF
* Refusing AVF

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No